Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 28;21(1):313-319.
doi: 10.5114/aoms/202123. eCollection 2025.

The role of GSDMs in the immune microenvironment of prostate cancer and their impact on patient prognosis: a comprehensive analysis based on the TCGA-PRAD database

Kai Liu  1 , Chundong D Ji  1 , Xuhua Qiao  1
Affiliations

The role of GSDMs in the immune microenvironment of prostate cancer and their impact on patient prognosis: a comprehensive analysis based on the TCGA-PRAD database

Kai Liu et al. Arch Med Sci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A – The relationship between GSDMs and immune cell infiltration; B – Correlation between GSDMs and matrix immune score; C – GSDMs relationship with survival curve, correlation between risk factors of D.C.OX prognostic model and GSDMs, D – Risk factor scores were correlated with major immune cells
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Slaufova M, Karakaya T, Di Filippo M, Hennig P, Beer HD. The gasdermins: a pore-forming protein family expressed in the epidermis. Front Immunol 2023; 14: 1254150. - PMC - PubMed
    1. Du T, Gao J, Li P, et al. . Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med 2021; 11: e492. - PMC - PubMed
    1. DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol 2021; 21: 785–97. - PMC - PubMed
    1. Jiang J, Xu Y, Chen D, et al. . Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment. Aging 2024; 16: 11683–728. - PMC - PubMed
    1. Bao X, Sun M, Meng L, Zhang H, Yi X, Zhang P. Applications of pyroptosis activators in tumor immunotherapy. Mater Today Bio 2024; 28: 101191. - PMC - PubMed

LinkOut - more resources